share_log

Analyzing Upexi (NASDAQ:UPXI) and Exactus (OTCMKTS:EXDI)

Defense World ·  Dec 25, 2022 01:11

Upexi (NASDAQ:UPXI – Get Rating) and Exactus (OTCMKTS:EXDI – Get Rating) are both small-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, risk and profitability.

Profitability

This table compares Upexi and Exactus' net margins, return on equity and return on assets.

Get Upexi alerts:
Net Margins Return on Equity Return on Assets
Upexi -9.97% -13.93% -9.55%
Exactus N/A -3,272.69% -185.29%

Analyst Ratings

This is a summary of current ratings and price targets for Upexi and Exactus, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Upexi 0 0 1 0 3.00
Exactus 0 0 0 0 N/A
Upexi currently has a consensus target price of $7.00, suggesting a potential upside of 125.81%. Given Upexi's higher probable upside, analysts clearly believe Upexi is more favorable than Exactus.

Institutional and Insider Ownership

3.1% of Upexi shares are owned by institutional investors. Comparatively, 0.1% of Exactus shares are owned by institutional investors. 55.0% of Upexi shares are owned by insiders. Comparatively, 65.0% of Exactus shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Risk & Volatility

Upexi has a beta of 1.27, meaning that its stock price is 27% more volatile than the S&P 500. Comparatively, Exactus has a beta of 4.21, meaning that its stock price is 321% more volatile than the S&P 500.

Earnings & Valuation

This table compares Upexi and Exactus' gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Upexi $44.58 million 1.16 -$2.10 million N/A N/A
Exactus $2.07 million 28.07 -$9.46 million N/A N/A

Upexi has higher revenue and earnings than Exactus.

Summary

Upexi beats Exactus on 7 of the 11 factors compared between the two stocks.

About Upexi

(Get Rating)

Upexi, Inc. manufacture and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. Upexi, Inc. was incorporated in 2018 and is headquartered in Clearwater, Florida.

About Exactus

(Get Rating)

Exactus, Inc., is a farmer and manufacturer of hemp-derived phytocannabinoid products. The company sells its CBD products through its Green Goddess brand and third-party resellers. Exactus is engaged in producing industrial hemp from farms in Oregon and plans to extract and manufacture directly through cGMP facilities. Industrial hemp is a type of cannabis, defined by the federal government as having THC (tetrahydrocannabinol) content of 0.3 percent or less. THC is the psychoactive compound found in cannabis.

Receive News & Ratings for Upexi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Upexi and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment